Edition:
United States

Quest Diagnostics Inc (DGX)

DGX on New York Consolidated

105.46USD
25 Jul 2017
Change (% chg)

$-3.98 (-3.64%)
Prev Close
$109.44
Open
$108.00
Day's High
$108.74
Day's Low
$105.07
Volume
333,180
Avg. Vol
886,330
52-wk High
$112.96
52-wk Low
$79.12

DGX

Chart for DGX

About

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $14,974.18
Shares Outstanding(Mil.): 136.83
Dividend: 0.45
Yield (%): 1.64

Financials

  DGX Industry Sector
P/E (TTM): 21.90 29.68 15.73
EPS (TTM): 5.00 -- --
ROI: 8.37 7.16 -8.37
ROE: 15.17 11.44 -7.93

BRIEF-Quest Diagnostics to acquire Cape Cod Healthcare outreach laboratory business

* Quest Diagnostics announces intent to acquire Cape Cod Healthcare outreach laboratory business in Massachusetts

Jun 27 2017

BRIEF-Quest Diagnostics reports Q1 revenue of $1.9 bln

* FY2017 earnings per share view $5.46 -- Thomson Reuters I/B/E/S

Apr 20 2017

BRIEF-Vermillion say co, unit entered amendment No. 2 to testing, services agreement with Quest Diagnostics effective March 11, 2017

* Vermillion - co, unit entered amendment no. 2 to testing and services agreement with quest diagnostics incorporated effective March 11, 2017

Mar 13 2017

BRIEF-QUEST DIAGNOSTICS SAYS WILL ACQUIRE OUTREACH LABORATORY SERVICES OPERATIONS OF PEACEHEALTH LABORATORIES

* QUEST DIAGNOSTICS AND PEACEHEALTH FORMED TWO-PART ARRANGEMENT TO ENHANCE DELIVERY OF LABORATORY SERVICES TO COMMUNITIES IN OREGON, WASHINGTON, ALASKA

Feb 15 2017

BRIEF-Quest Diagnostics Partners with Montefiore Health System to deliver high-value, innovative laboratory services

* Quest Diagnostics Partners with Montefiore Health System to deliver high-value, innovative laboratory services

Jan 26 2017

Competitors

Earnings vs. Estimates